Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Replicel Life Sciences Inc
V.RP
Alternate Symbol(s):
REPCF
Technology
Scientific & Technical Instruments
RepliCel Life Sciences Inc. is a Canada-based regenerative medicine company. The Company is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair...
restoration. RCH-01 is an autologous cell therapy utilizing dermal sheath cup (DSC) cells isolated from the hair follicle to treat androgenetic alopecia. RCS-01 is an autologous cell therapy utilizing non-bulbar dermal sheath (NBDS) cells, a type of fibroblast cell isolated from the hair follicle to repair and regenerate tissue. RCT-01 provides a source of collagen expressing cells to the site of injury, addressing the underlying cause of tendinosis. It has also developed an injection device, DermaPrecise, which improves the administration of its cell therapy products and certain other injectables.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:RP)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(1)
•••
Year3000
X
View Profile
View Bullboard History
Comment by
Year3000
on Jan 15, 2024 4:44am
RE:RE:RE:RE:RE:RE:RE:RE:Enough Is enough
I guess my real question is 'how does that share price go up from this point forward realistically?' I'm truly struggling answer that question!
(9)
•••
bluemoons20
X
View Profile
View Bullboard History
Comment by
bluemoons20
on Jan 14, 2024 5:59pm
RE:RE:RE:RE:RE:RE:RE:Enough Is enough
Have to agree. I got sucked in at the beginning too. Always have to watch for the volume of trading. I it only trades a few shares per day ,
...more
Q Precious & Battery Metals to Drill Initial 1000 metres at La Corne and McKenzie East Gold Projects, Quebec
posted Apr 23, 2024 9:00am by
Q Precious & Battery Metals Corp
-
|
The Company is planning for an initial 1,000 metres of diamond drilling scheduled for mid- June 2024, with VMS targets on the La Corne South project at proposed depths ranging from 50 to 300 metres below surface as modelled by the EM survey and noted in historic drilling. TMC Geophysique completed deep-penetrating Pulse-EM -Time Domain Electromagnetic (TDEM) surveying on the claims that targeted ...read more
(1)
•••
Year3000
X
View Profile
View Bullboard History
Comment by
Year3000
on Jan 14, 2024 5:53pm
RE:RE:RE:RE:RE:RE:RE:Enough Is enough
I took a huge loss but decided I was best to escape with some dignity! The company has said the injector is coming soon for the last 5 years, they have no trials on the go, they lost the
...more
(30)
•••
Ingiboy
X
View Profile
View Bullboard History
Comment by
Ingiboy
on Jan 14, 2024 3:49pm
RE:RE:RE:RE:RE:RE:Enough Is enough
Not sure how many or when you sold those shares but you must have taken a beating because we have only traded once above $.09 in the last 2 1/2 months. I am sitting on a very large pile of useless
...more
(1)
•••
Year3000
X
View Profile
View Bullboard History
Comment by
Year3000
on Jan 12, 2024 4:10pm
RE:RE:RE:RE:RE:Enough Is enough
I completely agree! I have sold around 75% of my shares as I think the company is dead! I'd buy back shares but have know idea about the direction of the company anymore! I
...more
(30)
•••
Ingiboy
X
View Profile
View Bullboard History
Comment by
Ingiboy
on Jan 12, 2024 12:48pm
RE:RE:RE:RE:Enough Is enough
Yes Year3000 this is beginning to look grim. It they have nothing to update then we can conclude all aspects of this company are "dead in the water". This is very disturbing
...more
(1)
•••
Year3000
X
View Profile
View Bullboard History
Comment by
Year3000
on Jan 10, 2024 2:22pm
RE:RE:RE:Enough Is enough
And still no news yet!
(10)
•••
MetzGER
X
View Profile
View Bullboard History
Comment by
MetzGER
on Jan 08, 2024 12:03pm
RE:RE:RE:Enough Is enough
I will leave it Up to you
(30)
•••
Ingiboy
X
View Profile
View Bullboard History
Comment by
Ingiboy
on Jan 06, 2024 12:19pm
RE:RE:Enough Is enough
Metzger have you called ? I will leave it up to you to tell us what they told you. Somehow I don't imagine they will tell you much. I don't think we will get the whole story until
...more
(10)
•••
MetzGER
X
View Profile
View Bullboard History
Comment by
MetzGER
on Jan 06, 2024 2:52am
RE:Enough Is enough
Call them simply
(30)
•••
Ingiboy
X
View Profile
View Bullboard History
Post by
Ingiboy
on Jan 05, 2024 9:05pm
Enough Is enough
Most of us have given Andrew and the Directors some time to crank things up after the Holiday Season. Time is up. If I hear the "legal" excuse any longer I am going to loose it.
...more
(1)
•••
Year3000
X
View Profile
View Bullboard History
Comment by
Year3000
on Jan 04, 2024 2:22pm
RE:RE:RE:RE:RE:RE:RE:Trials
Anyone called Replicel yet? Lol
(30)
•••
Ingiboy
X
View Profile
View Bullboard History
Comment by
Ingiboy
on Jan 04, 2024 11:28am
RE:RE:RE:RE:Trials
Bellend "legal" could mean just about anything from: finding a manufacturer for the Dermal Injector making some sort of deal with Shiseido for RCH-01 a large pharma buying the company a
...more
(1)
•••
Year3000
X
View Profile
View Bullboard History
Comment by
Year3000
on Jan 04, 2024 10:10am
RE:RE:RE:RE:Trials
Did they mention anything of interest?
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Clinical Study
Discover a Green Resources Stock Scoring Record Quarterly Growth
Stage Set for Creation of a Leading Intermediate Gold Producer